4AB Analysis

AbbVie Inc.
Stock Exchange: XETRA
Sector: biotechnology
137.04
Last session price
137.04
Price now
Currency: EUR
Reporting currency: USD
ISIN: US00287Y1091
INN:
.

4AB financial statements

* Numbers in millions
Capitalization * 213 976
EV * 219 202
Number of shares * 1 667
EPS 2,77
Revenue * 45 804
Net income * 4 616
Operating profit * 12 561
Total liabilities * 137 468
Net debt * 77 607
Total assets * 150 565
Equity * 13 076
Cash and investments * 8 479
.

4AB valuation

P/E 46,36
P/B 16,36
P/S 4,67
E/P 2
P/FCF 12,74
.

4AB profitability

ROE 35%
ROA% 13%
ROIC% 10%